Aadi Bioscience Stock In The News

AADI Stock  USD 2.22  0.08  3.48%   
Our overall analysis of Aadi Bioscience's news coverage and content from conventional and social sources shows investors' bearish mood towards Aadi Bioscience. The specific impact of Aadi Bioscience news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Aadi Bioscience's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Aadi Bioscience headlines in addition to utilizing other, more conventional financial analysis modules. Check out Aadi Bioscience Backtesting and Aadi Bioscience Hype Analysis.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

Aadi Bioscience Today Top News and Investor Outlook

Yahoo News
15 Best Falling Stocks To Buy Now
https://finance.yahoo.com/news/15-best-falling-stocks-buy-160700921.html
 Neutral
Yahoo News
11 Cheap Small-Cap Stocks to Buy Before the Next Breakout
https://finance.yahoo.com/news/11-cheap-small-cap-stocks-021220290.html
 Bullish
Yahoo News
Mirati Therapeutics and Aadi Bioscience ...
https://finance.yahoo.com/news/mirati-therapeutics-aadi-bioscience-partner-120000326.html
 Neutral
Macroaxis News: globenewswire.com
Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes
https://www.globenewswire.com/news-release/2022/06/23/2467930/0/en/Aadi-Bioscience-to-Join-Russell-2000-and-Russell-3000-Indexes.html
 Bullish
Macroaxis News: globenewswire.com
Aadi Bioscience to Present at the Jefferies Global Healthcare Conference
https://www.globenewswire.com/news-release/2022/06/01/2454182/0/en/Aadi-Bioscience-to-Present-at-the-Jefferies-Global-Healthcare-Conference.html
 Neutral
Macroaxis News: globenewswire.com
Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications
https://www.globenewswire.com/news-release/2022/05/31/2453198/0/en/Aadi-Bioscience-Appoints-Marcy-Graham-Senior-Vice-President-Investor-Relations-and-Corporate-Communications.html
 Neutral
Macroaxis News: globenewswire.com
Aadi Bioscience Announces Exploratory Bi...
https://www.globenewswire.com/news-release/2022/05/26/2451676/0/en/Aadi-Bioscience-Announces-Exploratory-Biomarker-Data-from-Patients-in-Its-AMPECT-Trial-and-Expanded-Access-Program-to-be-Presented-at-2022-ASCO-Annual-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference
https://www.globenewswire.com/news-release/2022/05/18/2445840/0/en/Aadi-Bioscience-to-Present-at-the-H-C-Wainwright-Global-Investment-Conference.html
 Neutral
Macroaxis News: globenewswire.com
UPDATE -- Aadi Bioscience Reports First Quarter 2022 Financial Results and Provides a Corporate Update
https://www.globenewswire.com/news-release/2022/05/12/2441993/0/en/UPDATE-Aadi-Bioscience-Reports-First-Quarter-2022-Financial-Results-and-Provides-a-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
Aadi Bioscience Reports First Quarter 2022 Financial Results and Provides a Corporate Update
https://www.globenewswire.com/news-release/2022/05/12/2441776/0/en/Aadi-Bioscience-Reports-First-Quarter-2022-Financial-Results-and-Provides-a-Corporate-Update.html
 Neutral

Aadi Bioscience Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Aadi and other traded companies coverage with news coverage. We help investors stay connected with Aadi headlines for the 26th of November to make an informed investment decision based on correlating the impacts of news items on Aadi Stock performance. Please note that trading solely based on the Aadi Bioscience hype is not for everyone as timely availability and quick action are needed to avoid losses.
Aadi Bioscience's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Aadi Bioscience investors visualize upcoming and past events in order to time the market based on Aadi Bioscience noise-free hype analysis.
Aadi Bioscience stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Aadi earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Aadi Bioscience that are available to investors today. That information is available publicly through Aadi media outlets and privately through word of mouth or via Aadi internal channels. However, regardless of the origin, that massive amount of Aadi data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aadi Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aadi Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aadi Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aadi Bioscience alpha.

Aadi Largest EPS Surprises

Earnings surprises can significantly impact Aadi Bioscience's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-05-07
2020-03-31-0.09-0.1-0.0111 
2020-08-12
2020-06-300.270.23-0.0414 
2018-05-15
2018-03-31-0.23-0.27-0.0417 
2023-11-08
2023-09-30-0.72-0.60.1216 
2022-08-10
2022-06-30-0.75-0.87-0.1216 
2024-08-07
2024-06-30-0.69-0.540.1521 
View All Earnings Estimates

Aadi Bioscience Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Aadi Bioscience Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
12th of November 2024
BML Capital Management LLC Takes 4.12 Million Position in Aadi Bioscience, Inc. - MarketBe...
at news.google.com 
Gurufocus Stories at Macroaxis
6th of November 2024
Aadi Bioscience Inc Q3 2024 Earnings Revenue Hits 7. ...
at gurufocus.com 
Google News at Macroaxis
30th of October 2024
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update - Morningstar
at news.google.com 
Macroaxis News
2nd of October 2024
Disposition of 32558 shares by David Lennon of Aadi Bioscience subject to Rule 16b-3
at MacroaxisInsider 
Google News at Macroaxis
6th of September 2024
Aadi Bioscience executive chairman sells shares worth over 68,000 - Investing.com
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aadi Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aadi Bioscience's short interest history, or implied volatility extrapolated from Aadi Bioscience options trading.
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:
Check out Aadi Bioscience Backtesting and Aadi Bioscience Hype Analysis.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.28)
Revenue Per Share
0.929
Quarterly Revenue Growth
0.21
Return On Assets
(0.35)
Return On Equity
(0.66)
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.